GGrantIndex
← Leaderboards

David B Clifford

Washington University

$32,841,647
Attributed
$36,802,005
Total exposure
12
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.6M · FY200522
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$39,541,186 · 13

By mechanism

U01$24,219,434 · 3
UM1$8,874,216 · 2
R01$2,739,181 · 1
U10$1,905,463 · 1
U24$1,480,221 · 1
R21$275,440 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchNeurologicUniversitiesWashingtonFundingHiv InfectionsProgramsSiteChildhoodLeadershipClinical TrialsTranslational ResearchResearch PersonnelPerformanceClinical Research SiteClinical Trials NetworkDesignProtocols DocumentationMonitorAffectAdultTrainingAids Clinical Trial GroupRecruitment Activity

Grant awards (43)

Washington University Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)- RFA-NS-17-024$277,953
U24 · FY2022 · NS · contact PI
Washington University Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)- RFA-NS-17-024$288,274
U24 · FY2021 · NS · contact PI
Washington University Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)- RFA-NS-17-024$297,514
U24 · FY2020 · NS · contact PI
Washington University Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)- RFA-NS-17-024$305,480
U24 · FY2019 · NS · contact PI
Washington University Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)- RFA-NS-17-024$311,000
U24 · FY2018 · NS · contact PI
Washington University Network of Excellence in Neuroscience Clinical Trials Site$304,000
U10 · FY2017 · NS · contact PI
Vanderbilt HIV Clinical Trials Unit$1,224,853
UM1 · FY2016 · AI
Vanderbilt HIV Clinical Trials Unit$395,433
UM1 · FY2016 · AI
Washington University Network of Excellence in Neuroscience Clinical Trials Site$304,000
U10 · FY2016 · NS · contact PI
Vanderbilt HIV Clinical Trials Unit$1,603,813
UM1 · FY2015 · AI
Washington University Network of Excellence in Neuroscience Clinical Trials Site$198,250
U10 · FY2015 · NS · contact PI
Vanderbilt HIV Clinical Trials Unit$2,716,438
UM1 · FY2014 · AI
Washington University Network of Excellence in Neuroscience Clinical Trials Site$242,729
U10 · FY2014 · NS · contact PI
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT$1,415,585
UM1 · FY2013 · AI · contact PI
Washington University Network of Excellence in Neuroscience Clinical Trials Site$251,911
U10 · FY2013 · NS · contact PI
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT$1,518,094
UM1 · FY2012 · AI · contact PI
Washington University Network of Excellence in Neuroscience Clinical Trials Site$300,573
U10 · FY2012 · NS · contact PI
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT$1,435,641
U01 · FY2011 · AI · contact PI
Washington University Network of Excellence in Neuroscience Clinical Trials Site$304,000
U10 · FY2011 · NS · contact PI
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT$1,635,616
U01 · FY2010 · AI · contact PI
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT$1,102,644
U01 · FY2009 · AI · contact PI
Assessment of the Neurological Impact of HIV-2 in West Africa$124,280
R21 · FY2009 · MH · contact PI
NEUROLOGIC AIDS RESEARCH CONSORTIUM$2,430,942
U01 · FY2008 · NS · contact PI
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT$2,050,805
U01 · FY2008 · AI · contact PI
Assessment of the Neurological Impact of HIV-2 in West Africa$151,160
R21 · FY2008 · MH · contact PI
NEUROLOGIC AIDS RESEARCH CONSORTIUM$2,449,724
U01 · FY2007 · NS · contact PI
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT$1,490,118
U01 · FY2007 · AI · contact PI
CHARTER$7,420
M01 · FY2007 · RR · contact PI
ADULT AIDS CLINICAL TRIALS UNIT$1,411,698
U01 · FY2006 · AI · contact PI
"CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS OF RESEARCH" (CHARTER)$9,553
M01 · FY2006 · RR · contact PI
ADULT AIDS CLINICAL TRIALS UNIT$1,826,895
U01 · FY2005 · AI
NEUROLOGIC AIDS RESEARCH CONSORTIUM$1,685,161
U01 · FY2005 · NS
CONTROLLED STUDY OF PROSAPTIDE IN HIV NEUROPATHY$14,877
P20 · FY2005 · RR
"CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS OF RESEARCH" (CHARTER)$10,943
M01 · FY2005 · RR
NEUROLOGIC AIDS RESEARCH CONSORTIUM$2,429,555
U01 · FY2004 · NS
ADULT AIDS CLINICAL TRIALS UNIT$1,824,091
U01 · FY2004 · AI
"CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS OF RESEARCH" (CHARTER)$4,438
M01 · FY2004 · RR
NEUROLOGIC AIDS RESEARCH CONSORTIUM$2,446,544
U01 · FY2003 · NS
CIDOFOVIR FOR TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN AIDS$0
M01 · FY2002 · RR
NEUROLOGIC AIDS RESEARCH CONSORTIUM$1,369,301
R01 · FY2001 · NS
CIDOFOVIR FOR TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN AIDS$0
M01 · FY2001 · RR
NEUROLOGIC AIDS RESEARCH CONSORTIUM$1,369,880
R01 · FY2000 · NS
CIDOFOVIR FOR TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN AIDS$0
M01 · FY2000 · RR